Traditional Chinese medicine for treating recurrent aphthae
A technology for recurrent aphthous sores and traditional Chinese medicine, applied in the direction of medical formula, drug combination, medical preparations containing active ingredients, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0011] Embodiment 1: A kind of Chinese medicine for the treatment of recurrent aphthous ulcer is made up of the following components of raw material drug ratio: astragalus 30-35g, ginseng 10-12g, licorice 10-12g, angelica 20-25g, coptis 12- 15g, Dandelion 40-45g, Achyranthes bidentata 25-30g, Myrrh 10-12g, Dried Ginger 6-8g, Aconite 6-8g, Cinnamon 6-8g, Asarum 10-15g.
Embodiment 2
[0012] Embodiment 2: A kind of Chinese medicine for the treatment of recurrent aphtha, wherein the preferred weight ratio of various raw materials is: Astragalus 30g, Ginseng 10g, Radix Glycyrrhizae 10g, Angelica Sinensis 20g, Coptis Rhizoma 12g, Dandelion 40g, Achyranthes bidentata 25g, Myrrha 10g , dried ginger 4g, aconite 4g, cinnamon 4g, asarum 10g.
[0013] Summary of clinical efficacy:
[0014] One, general information: the Chinese medicine of the present invention has been used clinically for many years, treats 45 routine patients altogether, wherein 13 are women, 32 are men, the minimum age is 29 years old, and the maximum age is 67 years old. The longest course of disease was 3 years, and the shortest was 4 months. The person who took the medicine at most was 32 doses, and the minimum was 10 doses.
[0015] Clinical efficacy standard:
[0016] Cure: recurrent aphtha is cured, the clinical symptoms disappear, and those who have not recurred within one year.
[0017...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com